Edward talked about real-world evidence in oncology in Taiwan and shared his experience navigating oncology research. To wrap things up, he also gave a shout-out to National Cheng Kung University ha! Edward Lai #ACPE #PHDcenter #NationalChengKungUniversity

Population Health Data Center Year-End Party !

Trust in health care: how is it maintained when living with chronic pain? New articles on trigeminal neuralgia, parvovirus B19 infection, SGLT2 inhibitors and chronic kidney disease, and more. ➡️ cmaj.ca/content/197/7 #MedTwitter

We’re analyzing (early teaser) where the U.S. really gets its final drug dosages from—and early data is eye-opening. This is why drug supply chains must be protected from strain—including #tariffs. Global thinking is essential here.

"Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real‐World Databases from Korea and Taiwan", has been published by our international team! Read ascpt.onlinelibrary.wiley.com/doi/10.1002/cp…

Excited to share that our study has just been published in the #EuropeanHeartJournal! This is a nationwide case-crossover study to examine whether short-term increases in anticholinergic burden(#OHCA). academic.oup.com/eurheartj/adva…

New Article: Epidemiology and Burden of Illness of Lennox-Gastaut Syndrome in Taiwan: A Retrospective Cohort Study ift.tt/erN5uLc #PEM #FOAMed #PEMUPDATES

New in #ASNKidney360: SGLT2 inhibitors were associated with lower nephrolithiasis risk compared to DPP4i and GLP-1RA in patients with diabetes. Read more: kidney.pub/KID0981